Granted Patent B2

US 12,274,865 · App. 17/816,615 · Granted Apr 15, 2025

Inventors: Trevor Langley (Rensselaer, NY); Justin Bechstein (Philadelphia, PA); Jeremy Odegard (Hudson, WI); Sibgat Ulla (Rensselaer, NY); Daniel Halbig (Rensselaer, NY); Bryan Grygus (Clifton Park, NY); Prithvi Singh (Rensselaer, NY); Andrew Dumont (Rensselaer, NY); David Nett (Rensselaer, NY); Tasha Gillum (Rensselaer, NY); Ryan Ainsworth (Rensselaer, NY)

Assignee: Regeneron Pharmaceuticals, Inc.

A61M5/31505A61M5/3135A61M5/3146A61M5/31536A61M5/31583A61F9/0008A61M2005/3139A61M2005/31508A61M2005/3154A61M2205/584

Abstract

Claims (48)

1. A drug delivery device, comprising:

a body;

a flange coupled to the body, the flange including a channel defined by an interior surface and a groove formed in the interior surface; and

a plunger rod coupled to the flange, the plunger rod including a proximal end and an extension extending distally from the proximal end;

wherein the extension is configured to compress radially-inwards and engage the interior surface as the plunger rod moves relative to the flange by a first stroke, the groove is configured to receive the extension and the extension is configured to expand radially-outwards as the plunger rod rotates relative to the flange, and the extension is configured to engage the groove of the flange as the plunger rod moves relative to the flange by a second stroke.

2. The drug delivery device of claim 1 , wherein the plunger rod is positioned relative to the flange such that the extension is radially misaligned with the groove when the plunger rod is coupled to the flange in a first position.

3. The drug delivery device of claim 2 , wherein the plunger rod is positioned relative to the flange such that the extension is radially aligned with the groove when the plunger rod is coupled to the flange in a second position.

4. The drug delivery device of claim 3 , wherein the plunger rod is configured to move from the first position to the second position.

5. The drug delivery device of claim 4 , wherein the extension is compressed radially-inward to a compressed state when in the first position.

6. The drug delivery device of claim 4 , wherein the flange includes an opening formed along the interior surface of the flange; and

wherein the opening is configured to receive the extension when the plunger rod is coupled to the flange prior to moving to the first position.

7. The drug delivery device of claim 6 , wherein the flange is configured to inhibit proximal and rotational movement of the plunger rod relative to the channel when the extension is received in the opening;

wherein the extension is configured to exit the opening when the plunger rod moves distally relative to the flange towards the first position.

8. The drug delivery device of claim 4 , wherein the flange includes an indent formed along a bottom wall of the flange; and

wherein the indent is configured to receive the extension when the plunger rod moves distally relative to the flange from the second position to a third position.

9. The drug delivery device of claim 8 , wherein the extension is positioned proximal to the indent when the plunger rod is in one of the first position or the second position.

10. The drug delivery device of claim 8 , wherein the indent defines a depression along the bottom wall of the flange, wherein the depression is sized such that the extension does not contact the bottom wall when the plunger rod moves to the third position.

11. The drug delivery device of claim 8 , wherein the flange is configured to at least partially compress the extension radially-inward towards the indent upon the plunger rod moving to the third position.

12. The drug delivery device of claim 1 , wherein the flange is configured to inhibit proximal movement of the plunger rod relative to the channel when the groove receives the extension;

wherein the proximal end of the plunger rod is fixed within the flange when the extension is disposed within the groove.

13. The drug delivery device of claim 1 , wherein the drug delivery device is configured to generate a user feedback in response to the groove receiving the extension.

14. A drug delivery device, comprising:

a body storing a dose of medicament;

a flange coupled to the body, the flange including a sidewall, a channel defined by the sidewall, and a pair of grooves formed along an interior of the sidewall; and

a plunger rod coupled to the flange and at least partially disposed within the body, the plunger rod including a proximal end and a pair of extensions extending distally from the proximal end;

wherein the plunger rod is configured to prime the drug delivery device by moving a first stroke relative to the flange, thereby positioning the pair of extensions against the sidewall; and

wherein the plunger rod is configured to prepare the drug delivery device for delivering the dose of medicament by rotating relative to the flange, thereby generating a user feedback as the pair of extensions expand radially-outward from a compressed state to an extended state upon engaging the pair of grooves.

15. The drug delivery device of claim 14 , wherein the plunger rod is positioned relative to the flange such that the pair of extensions are radially misaligned with the pair of grooves when the plunger rod moves the first stroke, and the pair of extensions are radially aligned with the pair of grooves when the plunger rod is rotated relative to the flange.

16. The drug delivery device of claim 14 , wherein the plunger rod includes a protrusion extending radially-outward from an exterior of the proximal end, and the flange includes a slot formed along the sidewall; and

wherein, when the protrusion is misaligned with the slot, the flange restricts distal movement of the plunger rod through the channel to a first position, and when the protrusion is aligned with the slot, the flange restricts distal movement of the plunger rod through the channel to a second position when the protrusion abuts against the slot, the second position being positioned distal to the first position.

17. The drug delivery device of claim 14 , wherein the flange includes a cavity, a pair of ribs that extend into the cavity, and a pair of moveable tabs that extend into the channel; and

wherein the pair of ribs is configured to engage a top flange of the body and the pair of moveable tabs is configured to engage a shaft of the body, thereby coupling the flange to the body.

18. A drug delivery device, comprising:

a body;

a flange coupled to the body, the flange including a collar having a channel and a pair of grooves positioned along opposite sides of the channel; and

a plunger rod coupled to the flange with the channel configured to accept the plunger rod, the plunger rod including a proximal portion and a pair of extensions extending distally from opposite sides of the proximal portion;

wherein the plunger rod is longitudinally moveable and rotatable relative to the flange, wherein the plunger rod is configured to:

move distally relative to the flange by an initial stroke to prime the drug delivery device, wherein the pair of extensions are radially misaligned with and positioned outside of the pair of grooves as the plunger rod moves the initial stroke;

rotate relative to the flange to prepare the drug delivery device for delivering a dose of medicament from the body, wherein the pair of extensions radially align with and contact the pair of grooves, thereby generating an audible feedback, as the plunger rod rotates relative to the flange; and

move distally relative to the flange by a final stroke to deliver the dose of medicament from the drug delivery device, wherein the pair of extensions are maintained inside and in contact with the pair of grooves as the plunger rod moves the final stroke.

19. The drug delivery device of claim 18 , wherein the plunger rod includes a pair of protrusions extending radially-outward from the proximal portion, and the flange includes a pair of slots formed on a proximal end of the collar; and

wherein the flange restricts distal movement of the plunger rod through the channel to a first position when the pair of protrusions are misaligned with the pair of slots, and restricts distal movement of the plunger rod through the channel to a second position that is distal to the first position when the pair of protrusions are aligned with and received in the pair of slots.

20. The drug delivery device of claim 18 , wherein the flange is configured to inhibit proximal movement of the plunger rod relative to the channel when the pair of grooves receive the pair of extensions.

21. The drug delivery device of claim 18 , wherein the body includes a medicament that is configured to treat an eye disorder.

22. The drug delivery device of claim 21 , wherein the medicament includes an anti-VEGF agent, and the eye disorder includes an angiogenic eye disorder.

23. The drug delivery device of claim 22 , wherein the anti-VEGF agent is aflibercept.

24. The drug delivery device of claim 23 , wherein, in response to the flange controlling movement of the plunger rod relative to the body, the drug delivery device is configured to administer a volume of less than 75 μl of aflibercept to an eye of a patient.

25. The drug delivery device of claim 24 , wherein the injection of aflibercept has a concentration of at least 8 mg.

Assignments (1)

Continuity (7)

References Cited (400)